Ratos sells Medisize to Phillips Plastics

2011-07-08

This information is disclosed in accordance with the Securities Markets Act, the
Financial Instruments Trading Act or demands made in the exchange rules.

Ratos has signed an agreement to sell 100% of the shares in the subsidiary
Medisize to Phillips Plastics Corporation for approximately EUR 99.8m. The sale
will generate an exit gain for Ratos of approximately SEK 40m and an average
annual return (IRR) of approximately 4%. The sale is subject to approval from
the relevant competition authorities.
Medisize is an international contract manufacturer specialised in medical
devices for delivery and administration of drugs and pharmaceutical packaging as
well as development, manufacture and distribution of single-use plastic products
for anaesthesia and intensive care. Medisize has 860 employees and the head
office is located in Vantaa, Finland.
Ratos acquired Medifiq Healthcare, previously a division in the Finnish company
Perlos group, in 2006. Medisize Medical, a division within the Swiss group
Medisize Holding, was acquired in 2008. In conjunction with this merger the new
group was given the name Medisize. Medisize's sales totalled EUR 127.8m in 2010
with an operating profit (EBITA) of EUR 12.6m.
"In recent years, Medisize has improved its operational efficiency and made
major investments in the sales organisation and distribution. Medisize is a
highly competitive and profitable niche player that has earned the increased
confidence of major pharmaceutical companies due to the high quality of its
operations. With the global company Phillips Plastics as its new owner Medisize
can now take the next step, towards larger contracts and new geographic
markets," says Ratos's CEO Arne Karlsson.

The selling price for 100% of the shares (Equity Value) amounts to approximately
EUR 99.8m with an Enterprise Value of EUR 127.5m. Ratos's exit gain will amount
to approximately SEK 40m, calculated on the book value in Medisize at 31 March
2011. The final exit gain will be affected, among other things, by Ratos's share
of profits from Medisize during the period until final completion of the deal.
The average annual return (IRR) amounts to approximately 4%. Ratos's holding in
Medisize is 98%.
Phillips Plastics Corporation is a global contract manufacturer of high-tech
products as well as specially manufactured injection-moulded plastic and metal
products. Phillips Plastics has annual sales in excess of USD 250m and
approximately 1,500 employees.
The sale is subject to approval from the relevant competition authorities and
some other conditions and is expected to be completed during the third quarter.
For further information, please contact:
Arne Karlsson, CEO Ratos, +46 8 700 17 00
Emma Rheborg, Head of Corporate Communications and IR Ratos, +46 733 80 22 63
Financial calendar from Ratos:
Interim Report January - June 2011                   19 August 2011
Interim Report January - September 2011          9 November 2011
Ratos is a private equity conglomerate. The company's mission is to maximise
shareholder value over time through the professional, active and responsible
exercise of its ownership role in primarily medium to large unlisted Nordic
companies. Ratos's holdings include AH Industries, Anticimex, Arcus-Gruppen,
Biolin Scientific, Bisnode, Contex, DIAB, EuroMaint, Finnkino, GS-Hydro, Hafa
Bathroom Group, HL Display, Inwido, Jøtul, KVD Kvarndammen, Lindab, Medisize,
Mobile Climate Control, SB Seating and Stofa. Ratos is listed on Nasdaq OMX
Stockholm, and its market capitalisation is approximately SEK 39 billion.